𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Molecular monitoring in patients with chronic myelogenous leukemia

✍ Scribed by Giuseppe Saglio; Stefano Ulisciani; Milena Fava; Enrico Gottardi; Daniela Cilloni

Book ID
107540204
Publisher
Current Science Inc.
Year
2008
Tongue
English
Weight
174 KB
Volume
3
Category
Article
ISSN
1558-8211

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Molecular diagnosis and monitoring in th
Molecular diagnosis and monitoring in the clinical management of patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors
✍ Joyce Ou; Jo-Anne Vergilio; Adam Bagg πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 161 KB πŸ‘ 2 views

## Abstract The well‐established molecular pathogenesis of chronic myelogenous leukemia (CML) and its consequences for laboratory testing and clinical management illustrate a classic paradigm for the importance of molecular diagnostics in targeted drug therapy. The success of the tyrosine kinase in

Chronic myelogenous leukemia: Laboratory
Chronic myelogenous leukemia: Laboratory diagnosis and monitoring
✍ Y. Lynn Wang; Adam Bagg; Warren Pear; Peter C. Nowell; Jay L. Hess πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 177 KB

## Abstract Rapid developments have occurred both in laboratory medicine and in therapeutic interventions for the management of patients with chronic myelogenous leukemia (CML). With a wide array of laboratory tests available, selecting the appropriate test for a specific diagnostic or therapeutic

Therapeutic choices in younger patients
Therapeutic choices in younger patients with chronic myelogenous leukemia
✍ Hagop M. Kantarjian; Francis J. Giles; Susan O'Brien; Sergio Giralt; Moshe Talpa πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 140 KB πŸ‘ 2 views

## Background: Allogeneic stem cell transplantation (sct) and interferon (ifn)-alpha therapy have significantly improved the prognosis of patients with philadelphia (ph) chromosome positive chronic myelogenous leukemia (cml). both therapies may be suitable for younger patients. the authors reviewed